Merck & Co Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (205)

View All

Latest Posts

About This Stock More About This Stock
Merck & Co Inc. DCF Valuation: Is The Stock Undervalued?
Article By: Tobias Carlisle
Friday, July 19, 2024 8:40 AM EDT
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections.
In this article: MRK
Read
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
Article By: Rod Raynovich
Monday, July 8, 2024 8:33 PM EDT
Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health.
In this article: MRK, PFE, UNH, SMID, REGN, GILD, VRTX, XBI, ABBV
Read
Which Is The Best Investment For You? High Yield Pfizer Or Higher Growth Merck?
Video By: Chuck Carnevale
Thursday, May 16, 2024 3:30 PM EDT
It depends on what your goals, objectives, and risk tolerances are.
In this video: MRK, PFE
Watch
Healthcare And Biotech Investing 101: What You Need To Know.
Article By: Rod Raynovich
Monday, May 13, 2024 4:44 AM EDT
Healthcare as a sector represents only about 12% of the S&P 500. If you want to overweight healthcare as a sector you need to add equities. Healthcare is usually a defensive sector because of demographics and government funding through Medicare.
In this article: LLY, MRK, TMO, UNH, FSMEX, REGN, XLV, ABBV
Read
Pharma Stock Roundup: Merck, Sanofi, AstraZeneca, Novartis' Q1 Results, Pipeline & Regulatory Updates
Article By: Zacks Investment Research
Sunday, April 28, 2024 4:00 PM EDT
The first-quarter 2024 earnings season picked up pace this week, with Merck, Sanofi, Novartis, and AstraZeneca announcing their first-quarter results. Three of the four companies beat estimates for both earnings and sales in the first quarter.
In this article: AZN, JNJ, MRK, NVS, SNY
Read
All Posts

Latest Tweets for $MRK

No tweets yet!

PARTNER HEADLINES

$MRK

Comments Status Updates
OncoSec Raising Its Profile In Fight Against Cancer
Harry Goldstein • 9/7/2017 5:43:14 PM

I appreciate a promising investment that also helps people. Bullish on $ONCS and $MRK.

OncoSec Raising Its Profile In Fight Against Cancer
Alexis Renault • 9/6/2017 4:08:15 PM

Thanks for this info, @[Terry Chrisomalis](user:5023). Is there any sort of official partnership or cooperation between #OncoSecMedical and #Merck to use ImmunoPulse IL-12 technology in conjunction with #Keytruda? $ONCS $MRK

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan • 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 3 of 3 comments